Screener
Galectin Therapeutics GALT Q2 2025 earnings
Reported August 14, 2025 · Before market open
EPS-$0.12Beat by $0.04
EPS estimate-$0.16
Next report
Nov 13, 2026 (in 2 months)EPS estimate-$0.05
Versus estimates
Diluted EPS
FAQ
- When did Galectin Therapeutics report Q2 2025 earnings?
- Galectin Therapeutics (GALT) reported Q2 2025 earnings on August 14, 2025 before market open.
- What were Galectin Therapeutics's Q2 2025 revenue and EPS?
- Galectin Therapeutics reported eps of $-0.12 for Q2 2025.
- Did Galectin Therapeutics beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.16 by $0.04.
- How did Galectin Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 40.0% from $-0.20.
- Where can I find Galectin Therapeutics's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001140361-25-031041) and the 10-Q periodic report (0001140361-25-031039) directly on SEC EDGAR. The filing index links above go to sec.gov.
